| Display title | Erythropoietin preserves VEcadherin appearance as well as barrier function throughout fresh diabetic person retinopathy by way of conquering VEGFVEGFR2Src signaling process |
| Default sort key | Erythropoietin preserves VEcadherin appearance as well as barrier function throughout fresh diabetic person retinopathy by way of conquering VEGFVEGFR2Src signaling process |
| Page length (in bytes) | 3,391 |
| Page ID | 1097581 |
| Page content language | English (en) |
| Page content model | wikitext |
| Indexing by robots | Allowed |
| Number of redirects to this page | 0 |
| Counted as a content page | Yes |
| Edit | Allow all users (infinite) |
| Move | Allow all users (infinite) |
| Page creator | Genderjelly6 (Talk | contribs) |
| Date of page creation | 09:58, 30 January 2024 |
| Latest editor | Genderjelly6 (Talk | contribs) |
| Date of latest edit | 09:58, 30 January 2024 |
| Total number of edits | 1 |
| Total number of distinct authors | 1 |
| Recent number of edits (within past 90 days) | 0 |
| Recent number of distinct authors | 0 |
